Latest Insights - page 57 | BiopharmaTrend

London Biotechnology Show Makes Grand Return to Unveil Cutting-Edge Advances in Health & Medicine

The London Biotechnology Show is set to return for its second edition in 2025, expanding significantly upon the foundation established by its debut event. Building on its initial success, the …

Continue ›››

Microbiotica's Microbiome Medicines Progress to Clinical Trials for Melanoma and Ulcerative Colitis

Microbiotica, a UK-based biopharma company specializing in precision microbiome medicines, has received regulatory approvals to start Phase 1b clinical trials for its leading programs targeting advanced melanoma and ulcerative colitis. …

Continue ›››

LG AI Research Introduces EXAONEPath: A Specialized Model for Histopathology Image Analysis

LG AI Research has unveiled EXAONEPath, a pre-trained model designed specifically for the analysis of histopathological images. These images are crucial in clinical medicine for diagnosing diseases and guiding treatment …

Continue ›››

Scientists Found a New Epigenetic Factor Preventing Inherited Diseases

Researchers at the University of Queensland have identified a crucial mechanism in mitochondrial DNA (mtDNA) that helps regulate the inheritance of disease-causing mutations. This mechanism involves a chemical modification called …

Continue ›››

Piramidal's AI: Transforming Neurological Diagnostics by Decoding Brainwaves

The complexity of the human brain, particularly the intricacies captured through electroencephalography (EEG), has long posed challenges in the field of neurology. These challenges are becoming increasingly manageable with the …

Continue ›››

Marketing Firm Supreme Group Acquires Life Science Specialist BioStrata

Supreme Group has announced the acquisition of BioStrata, a Cambridge-based marketing and public relations agency specializing in the life sciences. BioStrata is recognized for its comprehensive services across various life …

Continue ›››

BioPharma Industry Ranks High in Employee Wellbeing, According to a New Study

A recent study conducted by Great Place to Work has positioned the BioPharma sector among the top-ranking industries for employee wellbeing in the UK. The study, part of the "State …

Continue ›››

Reviving the Brain’s Waste Disposal System with a Labor-Inducing Drug

New research from the University of Rochester demonstrates the potential of a drug commonly used to induce labor in restoring the brain's waste disposal system, offering new hope for treating …

Continue ›››

Vandria Secures $30.7M in Series A to Push Mitophagy Drug into Clinical Trials

Vandria SA, a biotech company focused on mitochondrial therapeutics, has completed its Series A funding round, bringing in $30.7 million (CHF 28.3 million). New investors Hevolution Foundation and Dolby Family …

Continue ›››

Eli Lilly's Weight Loss Drug Shows Promise for Diabetes Prevention

Eli Lilly's weight loss drug tirzepatide has shown promising results in reducing the risk of developing Type 2 diabetes in overweight or obese adults with prediabetes, according to a late-stage …

Continue ›››

FUJIFILM's Subsidiary Unveils £100M Microbial Fermentation Facility in the UK, Tripling Production Capacity

FUJIFILM Diosynth Biotechnologies has opened a new £100 million microbial fermentation manufacturing facility in Billingham, UK, significantly expanding its production capabilities.

Continue ›››

ThermoFace: Revealing Biological Age and Hidden Health Risks via Your Face's Heat Map

In a groundbreaking study published in Cell Metabolism in July 2024, researchers introduced "ThermoFace," a mew method that utilizes thermal facial imaging to assess biological age and predict the presence …

Continue ›››